CAR-Ms can inhibit xenotransplantation of SKOV3 cells in vivo, enhance CD8+ T cell response in syngeneic tumor-bearing NCG mice with Hu-PBMC model, affect macrophage phenotype in TAM, and lead to tumor regression. Here, CD8A is linked to neoplasm.